HealthcareServices

Viral Inactivation Market Future Outlook 2026: Key Drivers and Growth Potential

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viral inactivation market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Viral Inactivation Market’s size between 2026 and 2030?

The viral inactivation market has experienced swift expansion recently. It is projected to grow from $5.47 billion in 2025 to $6.05 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The historical growth of this market can be attributed to several factors, including the increased production of plasma-derived products, the expansion in monoclonal antibody manufacturing, a rising regulatory focus on viral safety, the growth of biopharmaceutical manufacturing capacity, and the wider adoption of solvent detergent methods.

The viral inactivation market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $9.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This growth throughout the forecast period can be linked to the increasing demand for biologics and biosimilars, rising investments in advanced bioprocessing facilities, a growing focus on continuous manufacturing, the increasing adoption of automated quality control systems, and the expansion of vaccine production pipelines. Prominent trends for the forecast period include the increasing adoption of automated viral inactivation systems, a rising demand for validated virus safety processes, the growing use of continuous flow inactivation methods, the expansion of single-use bioprocessing solutions, and an enhanced focus on process reproducibility and compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

Which Drivers Are Shaping Strategic Decisions In The Viral Inactivation Market?

The increasing occurrence of various infectious diseases is projected to drive the expansion of the viral inactivation market in the future. These diseases are defined as ailments communicable between individuals, transmitted by contaminated food and drinks, or by disease-causing agents like viruses, bacteria, fungi, and parasites. Viral inactivation sees extensive application in human disease management initiatives, where it employs physical and chemical disinfectants to neutralize viruses, thereby curbing the spread of infectious viral illnesses and consequently stimulating the growth of the viral inactivation market. For example, data from March 2024, provided by the Centers for Disease Control and Prevention, a national public health agency in the United States, indicated a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. The corresponding rate also saw an ascent from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Consequently, the rising prevalence of diverse infectious diseases is serving as a key impetus for the expansion of the viral inactivation market.

What Segment Categories Are Covered In The Viral Inactivation Market?

The viral inactivation market covered in this report is segmented –

1) By Product: Kits And Reagents, Systems, Services

2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:

1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

3) By Services: Viral Testing Services, Validation Services, Consulting Services

What Upcoming Trends Are Likely To Define The Future Path Of The Viral Inactivation Market?

Companies active in the viral inactivation market are increasingly focusing on integrating advanced viral-clearance technologies to improve biologic safety, ensure regulatory compliance, and boost process efficiency. These technologies achieve viral inactivation through chemical, physical, or filtration-based mechanisms, providing capabilities such as log-reduction validation, ensuring regulatory-compliant viral safety, and enabling quicker decision-making in biologics development. For example, in May 2025, Northway Biotech, a Lithuania-based contract development and manufacturing organization (CDMO), introduced Full-Service Viral Clearance Studies (VCS). This sophisticated viral-clearance solution is designed to accelerate safety validation for protein biologics and gene therapies, featuring multiple identical BSL-2 laboratories for high-throughput workflows, BSL-3 testing capabilities, and delivering comprehensive regulatory-compliant viral clearance results in under 10 weeks, which is considerably faster than typical industry standards. This offering enhances development speed, assists with cost control, and improves regulatory readiness for biopharma clients.

Which Major Industry Participants Are Leading The Viral Inactivation Market Growth?

Major companies operating in the viral inactivation market are Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

Which Region Is Projected To Lead The Viral Inactivation Market During The Forecast Period?

North America was the largest region in the viral inactivation market in 2025. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viral Inactivation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp

Browse Through More Reports Similar to the Global Viral Inactivation Market 2026, By The Business Research Company

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Antivirals Market Report 2026

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795